The American Society of Hematology (ASH) holds a yearly conference in December to allow researchers and doctors in the blood cancer community an opportunity to share their research related to the newest developments in treatments, technologies, and more for blood cancers like AML.
This year, the conference will be held from December 9th-12th in San Diego, California. We look forward to meeting with AML specialists to cover the latest and greatest insights about AML and its care options. Following the event, expect to see HealthTree News articles and HealthTree University videos sharing what we learned at ASH from AML specialists.
We have found that patients who educate themselves about the facets of their disease are able to be better advocates for themselves and receive improved care and quality of life. Stay tuned for upcoming ASH content to learn about the latest in AML research.
The conference features a variety of sessions, including:
While the ASH conference is mainly for medical professionals, AML patients can also attend if they register. However, it's important to note that the technical nature of the presentations might be challenging for non-medical professionals to understand well.
Much of the discussed research from the conference is available on ASH’s website. To help make this information easy to understand for patients, HealthTree will be writing about topics discussed at the conference and sharing it with the HealthTree community in the form of HealthTree News articles and HealthTree University videos. Stay tuned for upcoming ASH content.
The American Society of Hematology's annual conference is a significant event for the blood cancer community, including those involved in AML research. This conference facilitates the sharing of groundbreaking research and developments in AML. While primarily aimed at medical professionals, AML patients are also welcome to attend once registered, though the technical nature of the presentations may be difficult to understand for non-specialists. HealthTree will help communicate important insights from the conference to the AML patient community to ensure they have the best opportunity to educate themselves about the latest in AML research.
The American Society of Hematology (ASH) holds a yearly conference in December to allow researchers and doctors in the blood cancer community an opportunity to share their research related to the newest developments in treatments, technologies, and more for blood cancers like AML.
This year, the conference will be held from December 9th-12th in San Diego, California. We look forward to meeting with AML specialists to cover the latest and greatest insights about AML and its care options. Following the event, expect to see HealthTree News articles and HealthTree University videos sharing what we learned at ASH from AML specialists.
We have found that patients who educate themselves about the facets of their disease are able to be better advocates for themselves and receive improved care and quality of life. Stay tuned for upcoming ASH content to learn about the latest in AML research.
The conference features a variety of sessions, including:
While the ASH conference is mainly for medical professionals, AML patients can also attend if they register. However, it's important to note that the technical nature of the presentations might be challenging for non-medical professionals to understand well.
Much of the discussed research from the conference is available on ASH’s website. To help make this information easy to understand for patients, HealthTree will be writing about topics discussed at the conference and sharing it with the HealthTree community in the form of HealthTree News articles and HealthTree University videos. Stay tuned for upcoming ASH content.
The American Society of Hematology's annual conference is a significant event for the blood cancer community, including those involved in AML research. This conference facilitates the sharing of groundbreaking research and developments in AML. While primarily aimed at medical professionals, AML patients are also welcome to attend once registered, though the technical nature of the presentations may be difficult to understand for non-specialists. HealthTree will help communicate important insights from the conference to the AML patient community to ensure they have the best opportunity to educate themselves about the latest in AML research.
about the author
Megan Heaps
Megan joined HealthTree in 2022. As a writer and the daughter of a blood cancer patient, she is dedicated to helping patients and their caregivers understand the various aspects of their disease. This understanding enables them to better advocate for themselves and improve their treatment outcomes. In her spare time, she enjoys spending time with her family, sewing, and cooking.
Subscribe to the weekly newsletter for news, stories, clinical trial updates, and helpful resources and events with cancer experts.